DAFTAR PUSTAKA

1. Roos KL, et al. 2005. Principles of Neurologic Infectious Disease. USA: The McGraw-Hill
Companies, Inc. p113-30
2. WHO. 2011. Global HIV/AIDS Response: Epidemic update and health sector progress toward
Universal Access. Progress Report 2011.
3. Duarte AG, Cikurel K, Simpson DM. Selected Neurologic Complications of HIV and
Antiretroviral Therapy. The PRN Notebook 2006; 11(2): 24-9
4. Ghafouri M, Amini S, Khalili K, Sawaya BE. HIV-1 associated dementia: symptoms and
causes. Retrovirology 2006; 3:28-39
5. Woods SP, Moore DJ, Weber E, Grant I. Cognitive Neuropsychology of HIV-Associated
Neurocognitive Disorders. Neuropsychol Rev 2009; 19:152168
6. Griffin PT, Gerhardstein K. Cognitive testing in HIV/AIDS: A case for early assessment. Fall
2010;22(4):6-9
7. Parsons T, Rogers S, Hall C, Robertson K. Motor based assessment of neurocognitive
functioning in resource-limited international settings. J Clinical and Experimental
Neuropsychology 2007;29: 59-66.
8. Lindl KA, et al. HIV-associated neurocognitive disorder: pathogenesis and therapeutic
opportunities. J Neuroimmune Pharmacol 2010; 5(3):294-309
9. Ellis R. HIV and antiretroviral therapy: impact on the central nervous system. Prog Neurobiol
2010; 91(2): 185-187
10. Clifford DB, et al. CSF biomarkers of Alzheimer disease in HIV-associated neurologic disease.
Neurology 2009;73:1982-7
11. Block ML, Zecca L, Hong JS. Microglia-mediated neurotoxicity: uncovering the molecular
mechanisms. Neuroscience 2007;8:57-65
12. Garsten M, et al. An Integrated Systems Analysis Implicates EGR1 Downregulation in Simian
Immunodeficiency Virus Encephalitis-Induced Neural Dysfunction. J Neurosci 2009;
29(40):1246712476
13. Price RW, et al. Enfuvirtide cerebrospinal fluid (CSF) pharmacokinetics and potential use in
defining CSF HIV-1 origin. Antivir Ther 2008;13(3): 369-374
14. Valcour V, et al. Screening for Cognitive Impairment in Human Immunodeficiency Virus. CID
2011;53(8): 836-42

15. Robbins RN, et al. Screening for HIV-Associated Dementia in South Africa: Potentials and
Pitfalls of Task-Shifting. AIDS PATIENT CARE and STDs 2011; 25(10):587-92
16. Lopes M, Brucki SMD, Giampaoli V, Mansur LL. Semantic Verbal Fluency test in dementia:
preliminary retrospective analysis. Dement Neuropsychol 2009;3(4):315-320
17. Robertson K, Liner J, Heaton R. Neuropsychological Assessment of HIV-Infected Populations
in International Settings. Neuropsychol Rev 2009; 19:232249
18. Wang T, Rumbaugh JA, Nath A. Viruses and the brain: from inflammation to dementia.
Clinical Science 2006; 110: 393407
19. Williams R, et al. Pro-inflammatory cytokines and HIV-1 synergistically enhance CXCL10
expression in human astrocytes. Glia 2009; 57(7): 734743
20. Heaton RK, et al. HIV-associated neurocognitive disorders persist in the era of potent
antiretroviral therapy: CHARTER Study. Neurology 2010;75(23): 2087-2096
21. Shaw FE, et al. Revised Surveillance Case Definitions for HIV Infection Among Adults,
Adolescents, and Children Aged <18 Months and for HIV Infection and AIDS Among Children
Aged 18 Months to <13 Years. MMWR 2008;57(10):1-12
22. Longo DL, et al. 2012. Harrisons Principles of Internal Medicine. 18th edition. USA:
McGraw-Hill Companies, Inc. p1132-59
23. Klatt EC. 2012. Pathology of AIDS. USA: Mercer University Press. p6-32
24. Ropper AH, Brown RH. 2005. Adams and Victors Principles of Neurology. Eighth edition.
New York: McGraw-Hill Companies, Inc. p644-648
25. Sadock BJ, Sadock VA. 2007. Kaplan and Sadocks Synopsis of Psychiatry: Behavioral
Sciences/Clinical Psychiatry. Tenth edition. USA: Lippincott Williams and Wilkins. p330-338
26. National Collaborating Centre for Mental Health. 2007. Dementia: A NICESCIE Guideline on
supporting people with dementia and their carers in health and social care. Great Britain:
The British Psychological Society and Gaskell.p66-70
27. Schouten J, et al. HIV-1 infection and cognitive impairment in the cART-era: a review. AIDS
2011;25:1-16
28. Lawler K, et al. Neurocognitive impairment among HIV-positive individuals in Botswana: a
pilot study. J International AIDS Society 2010; 13:15
29. Gallego L, Barreiro P, Lopez-Ibor JJ. Diagnosis and clinical features of major neuropsychiatric
disorders in HIV infection. AIDS Rev. 2011;13:171-9
30. Chan LG, Kandiah N, Chua A. HIV-associated neurocognitive disorders (HAND) in a South
Asian population - contextual application of the 2007 criteria. BMJ Open 2012;2:e000662

31. Qureshi et al. Estimation of the temporal probability of human immunodeficiency virus (HIV)
dementia after risk stratification for HIV-infected persons. Neurology 1998; 50:392-7
32. OARAC. 2012. Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and
Adolescents. AIDSinfo.
33. Campbell WW. 2005. DeJong's The Neurologic Examination. 6th Edition. USA: Lippincott
Williams and Wilkins. p
34. Oshinikae OO, et al. 2012. Comparison of theMinimental State Examination Scale and the
International HIV Dementia Scale in Assessing Cognitive Function in Nigerian HIV Patients on
Antiretroviral Therapy. Nigeria: Hindawi Publishing Corporation. p1-6
35. Mittal C, Gorthi CSP, Rohatgi MGS. Early Cognitive Impairment: Role of Clock Drawing Test.
MJAFI 2010; 66 : 25-8
36. Pokdi Fungsi Luhur. 2010. Panduan Pemeriksaan Neurologi dan Neurobehavior. Jakarta:
PERDOSSI.
37. Rosenberg PB, Johnston D, Lyketsos CG. A Clinical Approach to Mild Cognitive Impairment.
Am J Psychiatry 2006; 163(11): 1884-9
38. Sun X, et al. Age-dependent brain activation during forward and backward digit recall
revealed by fMRI. NeuroImage 2005;26:36-47
39. Woods SP, Moore DJ, Weber E, Grant I. Cognitive neuropsychology of HIV-associated
neurocognitive disorders. Neuropsychol Rev 2009;19:152-168
40. Budd MA. 2007. Boston Naming Test with Latencies (BNT-L). Dissertation. University of
North Texas. p43-7
41. Hall Jr, et al. Boston Naming Test: gender differences in older adults with and without
Alzheimers dementia. SciRes 2012;3(6):485-8
42. Zhang Y, et al. An initial screening for HIV-associated neurocognitive disorders of HIV-1
infected patients in China. J Neurovirol 2012;18:120-6
43. Sanchez-Cubillo I, et al. Construct validity of the Trail Making Test: Role of task-switching,
working memory, inhibition/interference control, and visuomotor abilities. J International
Neuropsychol Society 2009;15:438 450
44. Robertson KR, et al. The prevalence and incidence of neurocognitive impairment in the
HAART era. AIDS 2007; 21:191521
45. Owe-Larsson BL. HIV infection and psychiatric illness. Afr J Psychiatry 2009;12(2): 115-128.
46. Wang G, et al. Decreased brain dopaminergic transporters in HIV-associated dementia
patients. Brain 2004;127:24528
47. Power C, et al. NeuroAIDS: an evolving epidemic. Can J Neurol Sci 2009;36(3): 285-295.

48. Heaton RK, et al. HIV-associated neurocognitive disorders persist in the era of potent
antiretroviral therapy: CHARTER Study. Neurology 2010;75(23): 2087-2096.
49. Antinori A, et al. Italian Guidelines for the Use of Antiretroviral Agents and the Diagnosticclinical Management of HIV-1 Infected Persons. NEW MICROBIOLOGICA 2011; 34: 109-146
50. Brunton LL, et al. 2006. Goodman & Gilmans The Pharmacological Basis of Therapeutics.
11th edition. New York: McGraw-Hill Companies, Inc.
51. Best BM, et al. Low atazanavir concentrations in cerebrospinal fluid. Aids 2009;23(1): 83-87.
52. Schifitto G, et al. Selegiline and oxidative stress in HIVassociated cognitive impairment.
Neurology 2009;73(23): 1975-1981.
53. Schifitto G, et al. Memantine and HIV-associated cognitive impairment: a neuropsychological
and proton magnetic resonance spectroscopy study. Aids 2007; 21(14): 1877-1886.
54. Abbas AK, Lichtman AH, Pillai S. Cellular and Molecular Immunology. 6th edition.
Philadelphia: Elsevier, Inc. p481-5
55. Virella G. 2007. Medical Immunology. 6th edition. New York: Informa Healthcare USA, Inc.
p436-45
56. Dunfee RL, et al. The HIV Env variant N283 enhances macrophage tropism and is associated
with brain infection and dementia. PNAS 2006;103(41):15160-5
57. William R, et al. Pro-inflammatory cytokines and HIV-1 synergistically enhance CXCL10
expression in human astrocytes. Glia 2009; 57(7): 734743
58. Wang T, Rumbaugh JA, Nath A. Viruses and the brain: from inflammation to dementia.
Clinical Science 2006; 110, 393407
59. Shiramizu B, et al. Circulating proviral HIV DNA and HIV-associated dementia. AIDS 2005;
19:4552
60. Hagberg L, et al. Cerebrospinal fluid neopterin: an informative biomarker of central nervous
system immune activation in HIV-1 infection. AIDS Research and Therapy 2010; 7(1): 15.
61. Giunta B, et al. HIV-1 TAT Inhibits Microglial Phagocytosis of A Peptide. Int J Clin Exp Pathol
2008;1: 260-275